微信直播

Pierfillip Crucitti:当前致力于肺癌早期筛查,未来重在预防

Published at: 2015年第1卷第S1期

陆小雁
关键词:

编者按:2016年9月24-25日在北京国际会议中心成功举行了“2016年全国肺癌诊疗新技术新进展学习班”,同期举办了“第三届海峡两岸控烟与肺癌防治研讨会、中国胸外科肺癌联盟学术年会暨首届中意肺癌防治管理论坛”。AME编辑很荣幸邀请到Prof. Pierfillip Crucitti接受采访。分享了他们中心肺癌低剂量CT筛查的情况和经验,还特别提到他们正在积极推广的一项新技术BIONOTE e-nose technology。他说到,在意大利肺癌发病率比乳腺癌高,但是有乳腺癌的筛查项目,政府目前还不资助肺癌筛查,肺癌筛查仍需推进。目前最重要的任务是肺癌的早期筛查,以后会注重预防。更多详细内容,欢迎观看采访视频。

访谈视频

采访问题

  1. Self-introduction

  2. The experience at your center on lung cancer screening with low dose CT

  3. The advantages of traditional X-ray/Chest Examination and the current LDCT screening, e-nose technology etc.

  4. Some suggestions on lung cancer screening for China with such a large number of population

  5. How is the cost of prevention and treatment of lung cancer

  6. Programs in Italy on lung cancer screening or prevention

  7. Your opinions on the project that Mark Zuckerberg and Priscilla Chan start $3 billion initiative to cure disease

 

专家简介

Pierfillip Crucitti

  • Chief, Division of Thoracic Surgery, Department of General Surgery, Campus Bio Medico, University of Rome, Rome, Italy

  • Main areas of clinical activity: Oncology Surgery, Thoracic (Lung-Esophagus-Thymus) Endocrine Surgery

  • Responsible the national program on the early detection of lung cancer “Un Respiro per La Vita”

 

采访编辑:陆小雁

视频剪辑:麦雪芳

 

 

相关阅读:

doi: 

10.3978/kysj.2014.1.2183
comments powered by Disqus

附件